The tyrosine kinase Src is dysregulated in more than 80% of CRC cases, and increased expression of Src is related to a poor prognosis and can induce CRC cell growth, invasion, and drug resistance [19, 20, 38]. The gene discussed is SRC; the disease is colorectal carcinoma.